1Chobanian AV,Bakris GL,Blanck HR,et al.Seventh report of the joint national committee on detection.evaluation.and treatment of high blood pressure[J].JAMA,2003,289:2560-2572.
2Eastern stroke and coronary heart Disease collaborative research group.Blood pressure cholesterol and stroke in Eastern Asia[J].Lancet,1998,351:1801-1803.
3Alderman M,Aiyer KJ.Uric acid:role in cardiovascular disease and effects of losartan[J].Curr Med Res Opin,2004,20 (3):369-379.
4Henshaw CM.Alerationos in blood pressure.in:Copstead LC.Banasik JL.editors.Pathophysiology:Biological and behavioral perspective and edition Philadelphia:WB Sanuders CO,2004.374-392.
5Chae CU,Pfeffer MA,Glynn R J,et al Increased pulse pressure and risk of heart failute in the elderly[J].JAMA,1999,281:634-639.
6American Diabetes Association Clinical practice remmendations[J].Diabetes Care,2001,24 suppl:sl-133.
7Executive summary of the third report of the national cholesterol education program.evaluation and treatment of high blood cholesterol in adults (adult reatment panel Ⅲ)[J].JAMA,2001,285:2486-97.
8Shaw LJ,Lews JE,Hlaty MA,et al.Women.s ischemic syndrome.evaluation:current states future research directions:report the National Heart.lung and Biood Institute workshop; Octoker 2 -4,2002; Section 5:Gender related risk factors for ischemic heart disease[J].Circulation,2004,109 ;256-8.
9Stoney RM,O Dea K,Herkerk KE,et al.Insnlin resistamce as a major determinat of increased coronary heart disease risk in postmeno pausal women with type 2 diabetes mellitus[J].Diabet Med,2001,18(6):476-482.
10Duclos TW.Function of c-reactive protein[J].Ann Med,2000,32(4):274-278.
